GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma
Clinical trial NCT04917250 · UNKNOWN
Trial details
- NCT number
- NCT04917250
- Sponsor
- Beijing Tongren Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-20
- Primary completion
- 2021-06-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.